CheezhengTTM(SZ:002287) Zheng Quan Zhi Xing·2025-08-17 08:15Core Viewpoint - The company, Tibet Qizheng Tibetan Medicine Co., Ltd., has triggered the conditional redemption clause for its convertible bonds ("Qizheng Convertible Bonds") due to the stock price exceeding 130% of the conversion price for 15 consecutive trading days, leading to a decision for early redemption [2][7]. Group 1: Convertible Bond Redemption Details - The redemption price for "Qizheng Convertible Bonds" is set at 101.701 yuan per bond, including accrued interest [1][9]. - The company will redeem all unconverted "Qizheng Convertible Bonds" at the redemption price after the close of trading on the redemption registration date, September 2, 2025 [9][10]. - The total issuance of the convertible bonds was 800 million yuan, with each bond having a face value of 100 yuan [2][3]. Group 2: Conditions for Redemption - The redemption clause is triggered if the company's stock price remains above 130% of the conversion price (24.713 yuan) for 15 trading days [2][7]. - The company has the right to redeem the bonds if the unconverted balance is less than 30 million yuan [7]. Group 3: Historical Adjustments to Conversion Price - The conversion price has been adjusted multiple times since the issuance, with the latest adjustment on July 10, 2025, setting it at 19.01 yuan per share [7][8]. - The conversion period for the bonds started on March 29, 2021, and will end on September 21, 2026 [3][4]. Group 4: Redemption Process and Timeline - The redemption process will be managed by the company's management team, with the redemption funds expected to reach bondholders' accounts by September 10, 2025 [10]. - Bondholders must ensure that any pledged or frozen bonds are released before the conversion deadline to avoid forced redemption [1][10].